According to data released Monday by India’s Planning Commission, the number of people living in absolute poverty in India decreased by 12.5% between 2004-2005 and 2009-2010. India’s official poverty rate stands at 29.8%, or close to 350 million people using 2010 population figures, down from around 37.2% or 400 million previously. The announcement was based on an analysis of data gathered from roughly 100,000 households between July 2009 and June 2010,...

-The Economic Times Data released by the Planning Commission on Monday showed that poverty had significantly declined between 2004-05 and 2009-10. The catch is that this decline is based on a poverty line that is even lower than the earlier Rs 32-per-day mark that had triggered an outrage when the government submitted it to the Supreme Court.  The new estimates are based on a poverty line that averages Rs 672.8 per month...

-First Post A ten percent spike in food prices could push 30 millions more people into extreme poverty in India, a report by the Asian Development Bank (ADB) has said. Ironically,  data released by the Planning Commission on Monday showed that poverty had declined significantly between 2004-2005 and 2009-2010.In absolute terms, there were 35.5 crore poor people in 2009-10 against 40.7 crore five years earlier. As per the data, poverty across the...

At a time when economic wisdom is seen as lying in allowing unrestrained play of economic power and cutting social sector spending, here is a report emphasising the economic sense in addressing hunger, especially child malnutrition. It also brings out the positive impact of employment guarantee scheme, which has been a thrust area of the UPA government but has seen a cut in allocation in Budget proposals for 2012-13. The report...

Compulsory licence can go a long way to ensure access to cheaper drugs In a momentous development, the Indian patent office issued the ever-compulsory licence in a highly contentious pharmaceutical patent case. The decision is a thumping victory for several patients and health activists who have been fighting what can only be labelled as highly inequitable pricing strategies by multinational drug firms for the past several decades. In August 2011, Natco, an...